从解剖到功能与分子生物标志物成像及治疗:超声安全、超快、便携且廉价
本文综述超声成像从解剖成像向功能与分子成像及治疗应用的发展趋势,涵盖超快帧率、超声造影剂灌注成像、超分辨微血管成像、分子超声靶向内皮生物标志物、聚焦超声消融及血脑屏障开放递药,指出超声正快速进步并可能帮助解决现代医学面临的许多问题。
要点
- 超声已超越传统解剖成像,造影剂灌注成像和超分辨成像可显示毛细血管及血流速度。
- 靶向内皮生物标志物的微泡分子超声可选择性蓄积于缺血、炎症或新生血管区域。
- 聚焦超声可毫米精度消融深部病灶,联合微泡可开放血脑屏障递药,已进入临床试验阶段。
核心结论
- 医学超声正以 brisk 速度发展,即使在其他成像方式也快速进步且可能更有利可图的环境中也是如此。
- 随着本文讨论的当前进展及未来更多进展,超声可能帮助解决现代医学面临的许多问题。
研究设计与样本
- 本文为综述,讨论超声成像的当前发展趋势,未报告检索范围与纳入文献数量。
关键影像表现/征象
- 超声已从解剖成像和大血管血流监测进展到组织灌注研究,临床批准的超声造影剂(充气微泡)经血流给药后灌注研究已常规开展。
- 现代超声脉冲序列可检测并实时观察单个亚皮克质量的微泡,深度可达体内数厘米。
- 通过追踪血管内微泡位置实现超分辨成像,可追踪最小血管和毛细血管并获得其血流速度数据。
- 对血管内皮生物标志物具有特异亲和力的微泡可使超声造影剂选择性蓄积并滞留于缺血损伤、炎症或新生血管区域。
- 超声场可在体内数厘米深处以毫米精度紧密聚焦,通过热或机械生物效应沉积能量消融病灶。
临床应用与阅片要点
- 分子超声成像已更接近临床,可能为非侵入性分子成像提供帮助,并可能为活检、手术和消融操作的实时引导提供额外帮助。
- 部分聚焦超声治疗已用于临床,更多适应证正在临床试验阶段推进。
- 血管内微泡联合循环药物和低功率超声可短暂开放血管内皮屏障(包括血脑屏障),该途径已进入临床试验阶段。
- 血管内微泡联合聚焦超声可用于组织特异性药物递送;从血流中颗粒局部触发释放隔离药物可能需要时间才能进入临床。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ultrasound is the most widely used medical imaging modality worldwide. It is abundant, extremely safe, portable, and inexpensive. In this review, we consider some of the current development trends for ultrasound imaging, which build upon its current strength and the popularity it experiences among medical imaging professional users.Ultrasound has rapidly expanded beyond traditional radiology departments and cardiology practices. Computing power and data processing capabilities of commonly available electronics put ultrasound systems in a lab coat pocket or on a user's mobile phone. Taking advantage of new contributions and discoveries in ultrasound physics, signal processing algorithms, and electronics, the performance of ultrasound systems and transducers have progressed in terms of them becoming smaller, with higher imaging performance, and having lower cost. Ultrasound operates in real time, now at ultrafast speeds; kilohertz frame rates are already achieved by many systems.Ultrasound has progressed beyond anatomical imaging and monitoring blood flow in large vessels. With clinical approval of ultrasound contrast agents (gas-filled microbubbles) that are administered in the bloodstream, tissue perfusion studies are now routine. Through the use of modern ultrasound pulse sequences, individual microbubbles, with subpicogram mass, can be detected and observed in real time, many centimeters deep in the body. Ultrasound imaging has broken the wavelength barrier; by tracking positions of microbubbles within the vasculature, superresolution imaging has been made possible. Ultrasound can now trace the smallest vessels and capillaries, and obtain blood velocity data in those vessels.Molecular ultrasound imaging has now moved closer to clinic; the use of microbubbles with a specific affinity to endothelial biomarkers allows selective accumulation and retention of ultrasound contrast in the areas of ischemic injury, inflammation, or neoangiogenesis. This will aid in noninvasive molecular imaging and may provide additional help with real-time guidance of biopsy, surgery, and ablation procedures.The ultrasound field can be tightly focused inside the body, many centimeters deep, with millimeter precision, and ablate lesions by energy deposition, with thermal or mechanical bioeffects. Some of such treatments are already in clinical use, with more indications progressing through the clinical trial stage. In conjunction with intravascular microbubbles, focused ultrasound can be used for tissue-specific drug delivery; localized triggered release of sequestered drugs from particles in the bloodstream may take time to get to clinic. A combination of intravascular microbubbles with circulating drug and low-power ultrasound allows transient opening of vascular endothelial barriers, including blood-brain barrier; this approach has reached clinical trial stage. Therefore, the drugs that normally would not be getting to the target tissue in the brain will now have an opportunity to produce therapeutic efficacy.Overall, medical ultrasound is developing at a brisk rate, even in an environment where other imaging modalities are also advancing rapidly and may be considered more lucrative. With all the current advances that we discuss, and many more to come, ultrasound may help solve many problems that modern medicine is facing.
引用
- Wang S, Hossack JA, Klibanov AL, et al. From Anatomy to Functional and Molecular Biomarker Imaging and Therapy: Ultrasound Is Safe, Ultrafast, Portable, and Inexpensive. Invest Radiol. 2020. PMID: 32776766. doi:10.1097/RLI.0000000000000675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。